Table 3 Odds of Major Adverse Cardiac Event (MACE) from multivariable logistic models, adjusting for the baseline data including age, gender, BMI and other available patient characteristics
Overall | ||
OR (95% CI) | p-value | |
CVD (-) | Reference | |
CVD ( +) | 1.14 (1.11–1.17) | < 0.001 |
Cardioonc (-) | 1.33 (1.31–1.36) | < 0.001 |
Cardioonc ( +) | 1.66 (1.47–1.87) | < 0.001 |
Early SARS-CoV-2 | ||
OR (95% CI) | p-value | |
CVD (-) | Reference | |
CVD ( +) | 1.24 (1.20–1.28) | < 0.001 |
Cardioonc (-) | 1.43 (1.40–1.46) | < 0.001 |
Cardioonc ( +) | 1.93 (1.63–2.28) | < 0.001 |
Alpha | ||
OR (95% CI) | p-value | |
CVD (-) | Reference | |
CVD ( +) | 1.14 (1.08–1.20) | < 0.001 |
Cardioonc (-) | 1.10 (1.04–1.16) | < 0.001 |
Cardioonc ( +) | 1.86 (1.44–2.40) | < 0.001 |
Delta | ||
OR (95% CI) | p-value | |
CVD (-) | Reference | |
CVD ( +) | 1.06 (0.99–1.13) | 0.07 |
Cardioonc (-) | 0.96 (0.90–1.03) | 0.3 |
Cardioonc ( +) | 1.24 (0.93–1.65) | 0.07 |
Omicron | ||
OR (95% CI) | p-value | |
CVD (-) | Reference | |
CVD ( +) | 0.99 (0.88–1.12) | 0.96 |
Cardioonc (-) | 0.71 (0.60–0.84) | < 0.001 |
Cardioonc ( +) | 0.89 (0.49–1.62) | 0.71 |